ATP2B1-AS1
geneOn this page
Summary
ATP2B1-AS1 (ATP2B1 antisense RNA 1, HGNC:27883) is a long non-coding RNA gene on chromosome 12q21.33.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27883 |
| Approved symbol | ATP2B1-AS1 |
| Name | ATP2B1 antisense RNA 1 |
| Location | 12q21.33 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000271614 |
| Ensembl biotype | lncRNA |
| Entrez | 338758 |
| RNAcentral | URS000075E810 — lncRNA, 2998 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 50 — 50 lncRNA
ENST00000547370, ENST00000549551, ENST00000651272, ENST00000652964, ENST00000716128, ENST00000716129, ENST00000716130, ENST00000716131, ENST00000716132, ENST00000716133, ENST00000716134, ENST00000716135, ENST00000716136, ENST00000716137, ENST00000716138, ENST00000739864, ENST00000739865, ENST00000739866, ENST00000739867, ENST00000820483, ENST00000820484, ENST00000820485, ENST00000820486, ENST00000820487, ENST00000820488, ENST00000820489, ENST00000820490, ENST00000820491, ENST00000820492, ENST00000820493, ENST00000820494, ENST00000820495, ENST00000820496, ENST00000820497, ENST00000820498, ENST00000820499, ENST00000820500, ENST00000820501, ENST00000820502, ENST00000820503, ENST00000820504, ENST00000820505, ENST00000820506, ENST00000820507, ENST00000820508, ENST00000820509, ENST00000820510, ENST00000820511, ENST00000820512, ENST00000820513
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000547370 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002333662 | 89921067 | 89921169 |
| ENSE00002348331 | 89882665 | 89882891 |
| ENSE00002377452 | 89935822 | 89935987 |
| ENSE00002391786 | 89937093 | 89937143 |
Expression profiles
Bgee: expression breadth ubiquitous, 222 present calls, max score 98.17.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.4302 / max 865.2991, expressed in 1498 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127260 | 11.4975 | 1247 |
| 127257 | 1.6357 | 470 |
| 127256 | 1.3158 | 454 |
| 127262 | 0.3187 | 77 |
| 127261 | 0.3082 | 127 |
| 127259 | 0.2317 | 94 |
| 127258 | 0.1225 | 41 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 98.17 | gold quality |
| endothelial cell | CL:0000115 | 94.45 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 92.11 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 91.99 | gold quality |
| buccal mucosa cell | CL:0002336 | 89.32 | silver quality |
| entorhinal cortex | UBERON:0002728 | 88.81 | gold quality |
| cartilage tissue | UBERON:0002418 | 87.83 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 86.19 | gold quality |
| postcentral gyrus | UBERON:0002581 | 85.48 | gold quality |
| parietal lobe | UBERON:0001872 | 85.47 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.24 | gold quality |
| occipital lobe | UBERON:0002021 | 83.42 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 82.71 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 82.47 | gold quality |
| cerebellar vermis | UBERON:0004720 | 82.35 | gold quality |
| monocyte | CL:0000576 | 81.86 | gold quality |
| granulocyte | CL:0000094 | 81.53 | gold quality |
| leukocyte | CL:0000738 | 81.27 | gold quality |
| bone marrow | UBERON:0002371 | 81.06 | gold quality |
| nucleus accumbens | UBERON:0001882 | 80.44 | gold quality |
| temporal lobe | UBERON:0001871 | 79.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.87 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.77 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 78.68 | silver quality |
| frontal cortex | UBERON:0001870 | 78.64 | gold quality |
| cerebral cortex | UBERON:0000956 | 78.21 | gold quality |
| neocortex | UBERON:0001950 | 78.20 | gold quality |
| skin of hip | UBERON:0001554 | 78.10 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 78.09 | silver quality |
| lower lobe of lung | UBERON:0008949 | 77.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.21 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- Silencing of ATP2B1-AS1 contributes to protection against myocardial infarction in mouse via blocking NFKBIA-mediated NF-kappaB signalling pathway. (PMID:32155320)
- Elevated linc00936 or silenced microRNA-425-3p inhibits immune escape of gastric cancer cells via elevation of ZC3H12A. (PMID:33756228)
- Long non-coding ribonucleic acid ATP2B1-AS1 modulates endothelial permeability through regulating the miR-4729-IQGAP2 axis in diabetic retinopathy. (PMID:34935307)
- LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3. (PMID:35297352)
- LINC00936 exacerbated myocardial infarction progression via miR-4795-3p/Wnt3a signaling pathway based on biological and imaging methods. (PMID:35410528)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): small cell lung carcinoma